Zhang, Jin
https://orcid.org/0000-0003-0197-3624
Mayo Clinic
Merck & Co., Inc., Rahway, NJ, USA (United States)
Citations 1
Safety and clinical activity of MK-3475 as initial therapy in patients with advanced non-small cell lung cancer (NSCLC).
Rizvi, Naiyer A. , Patnaik, Amita , Balmanoukian, Ani Sarkis, Blumenschein, George R. , Gubens, Matthew A. , Papadopoulos, Kyriakos P. , Lubiniecki, Gregory M., Zhang, Jin , Niewood, Michelle, Emancipator, Kenneth , Dolled‐Filhart, Marisa, Hanson, Mary E. , Hui, Rina , Garon, Edward B. , Gandhi, Leena , Leighl, Natasha B , Goldman, Jonathan W. , Eder, Joseph P. , Johnson, Elizabeth Anne
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8007-8007
